AVITA Medical Issues 267,533 Shares in Cashless Warrant Exercises
AVITA Medical (RCEL) issued 267,533 shares following cashless warrant exercises by Perceptive and OrbiMed. Perceptive received 119,375 shares, while OrBiMed received 148,158 shares. The exercises were disclosed in filings with the Australian Securities Exchange on November 13, 2026.
How this was made

The 30-second read
Why it matters
The issuance of new shares modestly expands the float and could exert slight downward pressure on the stock price.
Market read
Microcap share dilution news with limited broader market impact.
What to watch
Potential strategic benefit from the investors (Perceptive, OrbiMed) retaining stakes after exercise.
Background
AVITA Medical filed an 8‑K with the SEC reporting the cashless warrant exercises disclosed on the Australian Securities Exchange.
Ticker impact
AVITA Medical disclosed cashless exercise of warrants, issuing 267,533 new shares on Nov 11, 2026.
likely slight downward pressure as market prices in the dilution
New shares issued without cash raise can dilute earnings per share; impact is limited given the small absolute number.
Market effects
Minimal effect on the broader biotech/medical device sector.
Limited to U.S. microcap investors tracking AVITA Medical.
None
Counterpoint
The dilution may be offset by upcoming product milestones, making the share increase less concerning.
Key entities
- CompanyAVITA Medical
Medical device and biotech firm issuing new shares via warrant exercises.
- InvestorPerceptive
Investor exercising warrants in AVITA Medical.
- InvestorOrbiMed
Investor exercising warrants in AVITA Medical.

